Publication | Open Access

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects

OncologyMedicineBronchial NeoplasmClinical AspectsPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyRadiation OncologyLung Cancer